Abstract: The present invention is generally directed to substantially pure cannabidiol, stable cannabinoid pharmaceutical formulations, and methods of their use.

Abstract: The present invention is generally directed to substantially pure cannabidiol, stable cannabinoid pharmaceutical formulations, and methods of their use.

Abstract: The present invention is generally directed to substantially pure cannabidiol, stable cannabinoid pharmaceutical formulations, and methods of their use.

Abstract: The present invention is generally directed to substantially pure cannabidiol, stable cannabinoid pharmaceutical formulations, and methods of their use.

Abstract: The present invention is generally directed to substantially pure cannabidiol, stable cannabinoid pharmaceutical formulations, and methods of their use.

Abstract: The present invention is generally directed to substantially pure cannabidiol, stable cannabinoid pharmaceutical formulations, and methods of their use.

Abstract: The present invention is generally directed to substantially pure cannabidiol, stable cannabinoid pharmaceutical formulations, and methods of their use.

Abstract: The present invention is generally directed to substantially pure cannabidiol, stable cannabinoid pharmaceutical formulations, and methods of their use.

Abstract: The present invention is generally directed to substantially pure cannabidiol, stable cannabinoid pharmaceutical formulations, and methods of their use.

Abstract: The present invention is generally directed to substantially pure cannabidiol, stable cannabinoid pharmaceutical formulations, and methods of their use.

Abstract: The present invention is generally directed to substantially pure cannabidiol, stable cannabinoid pharmaceutical formulations, and methods of their use.

Abstract: The present invention is generally directed to substantially pure cannabidiol, stable cannabinoid pharmaceutical formulations, and methods of their use.

Abstract: The present invention is generally directed to substantially pure cannabidiol, stable cannabinoid pharmaceutical formulations, and methods of their use.

Abstract: Embodiments of a system and method for using radio frequency (RF) resources are generally described herein. In some embodiments, the system includes an antenna subsystem including antenna apertures. The system may also include devices configured to execute a plurality RF tasks. The system may further include memory to store a prioritized list of RF tasks. The system may still further include a manager to receive a request from an RF task to use an antenna aperture. The manager may insert the RF task into a prioritized list of RF tasks within a time duration specified in the request. The manager may spawn a thread to execute the RF task through the antenna aperture, within a time frame depending on the RF task's position in the prioritized list.

Abstract: A novel method for designing an integrated circuit (“IC”) by rescaling an original set of circuits in a design of the IC is disclosed. The original set of circuits to be rescaled includes sequential nodes, combinational nodes, and interconnects. Each sequential node is associated with a phase of a clock. The method generates a rescaled set of circuits that includes multiple replica sets of the circuits. Each replica set of circuits includes sequential nodes, combinational nodes, and interconnects that are identical to nodes and interconnects in the original set of circuits. Each sequential node is associated with a phase of a clock that is at a fraction of the phase of its corresponding sequential element in the original set. The method connects nodes in each replica set of circuits to a logically equivalent node in another replica set. The method replaces the original set of circuits with the rescaled set of circuits.

Abstract: The present invention is generally directed to substantially pure cannabidiol, stable cannabinoid pharmaceutical formulations, and methods of their use.

Abstract: The present invention is generally directed to substantially pure cannabidiol, stable cannabinoid pharmaceutical formulations, and methods of their use.

Abstract: Embodiments of a system and method for using radio frequency (RF) resources are generally described herein. In some embodiments, the system includes an antenna subsystem including antenna apertures. The system may also include devices configured to execute a plurality RF tasks. The system may further include memory to store a prioritized list of RF tasks. The system may still further include a manager to receive a request from an RF task to use an antenna aperture. The manager may insert the RF task into a prioritized list of RF tasks within a time duration specified in the request. The manager may spawn a thread to execute the RF task through the antenna aperture, within a time frame depending on the RF task's position in the prioritized list.

Abstract: Disclosed is a DNA encoding a composition of matter of the formula (X1)a—(F1)d—(X2)b—(F2)e—(X3)c??(I) and multimers thereof, in which F1 and F2 are half-life extending moieties, and d and e are each independently 0 or 1, provided that at least one of d and e is 1; X1, X2, and X3 are each independently -(L)f-P-(L)g-, and f and g are each independently 0 or 1; P is a ShK peptide analog of no more than about 80 amino acid residues in length; L is an optional linker; and a, b, and c are each independently 0 or 1, provided that at least one of a, b and c is 1. A DNA encoding the ShK peptide analog is disclosed. Also disclosed are an expression vector comprising the DNA, and a host cell comprising the expression vector.

Abstract: A novel method for designing an integrated circuit (“IC”) by rescaling an original set of circuits in a design of the IC is disclosed. The original set of circuits to be rescaled includes sequential nodes, combinational nodes, and interconnects. Each sequential node is associated with a phase of a clock. The method generates a rescaled set of circuits that includes multiple replica sets of the circuits. Each replica set of circuits includes sequential nodes, combinational nodes, and interconnects that are identical to nodes and interconnects in the original set of circuits. Each sequential node is associated with a phase of a clock that is at a fraction of the phase of its corresponding sequential element in the original set. The method connects nodes in each replica set of circuits to a logically equivalent node in another replica set. The method replaces the original set of circuits with the rescaled set of circuits.